USPTO serial 79367291
CINPINETY
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 30, 2024
- Examiner
- FLETCHER, TRACY L
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with CINPINETY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Zhuhai Trinomab Pharmaceutical Co., Ltd.
CN
Other trademarks owned by Zhuhai Trinomab Pharmaceutical Co., Ltd.
Zhuhai Trinomab Pharmaceutical Co., Ltd.
CN
Other trademarks owned by Zhuhai Trinomab Pharmaceutical Co., Ltd.
Zhuhai Trinomab Pharmaceutical Co., Ltd.
CN
Other trademarks owned by Zhuhai Trinomab Pharmaceutical Co., Ltd.
Zhuhai Trinomab Pharmaceutical Co., Ltd.
CN
Other trademarks owned by Zhuhai Trinomab Pharmaceutical Co., Ltd.
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Scot A. Duvall
Scot A. Duvall STITES & HARBISON PLLC250 W. Main Street, Suite 2300Lexington, KY 40507United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Drugs for medical purposes, namely, pharmaceutical preparations for the treatment of cancer; drugs for medical purposes, namely, pharmaceutical preparations for the prevention and treatment of respiratory system disorders; drugs for medical purposes, namely, pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; drugs for medical purposes, namely, pharmaceutical preparations for the prevention and treatment of infectious diseases, pain, cancer and tumors; pharmaceutical preparations for the prevention and treatment of respiratory system disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of infectious diseases, pain, cancer and tumors; biological preparations for medical purposes, namely, biological preparations for the treatment of cancer; biological preparations for medical purposes for the prevention and treatment of respiratory system disorders; biological preparations for medical purposes for the prevention and treatment of immune system related diseases and disorders; biological preparations for medical purposes for the prevention and treatment of infectious diseases, pain, cancer and tumors; vaccines; medicines for human purposes, namely, pharmaceutical preparations for the treatment of cancer and antibiotics; medicines for human purposes for the prevention and treatment of respiratory system disorders; medicines for human purposes for the prevention and treatment of immune system related diseases and disorders; medicines for human purposes for the prevention and treatment of infectious diseases, pain, cancer and tumors; diagnostic preparations for medical purposes; dietetic foods and beverages adapted for medical use; dietetic preparations adapted for medical purposes, namely, dietetic foods and beverages adapted for medical use; protein supplements for animals; absorbent wadding for medical purposes | ACTIVE | — |
| 035 | Retail store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; wholesale distributorship services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; marketing services; commercial administration of the licensing of the goods and services of others; providing television home shopping services in the field of general consumer merchandise; advertising services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Zhuhai Trinomab Pharmaceutical Co., Ltd.
- Other trademarks owned by Zhuhai Trinomab Pharmaceutical Co., Ltd.
- Other trademarks owned by Zhuhai Trinomab Pharmaceutical Co., Ltd.
- Other trademarks owned by Zhuhai Trinomab Pharmaceutical Co., Ltd.
- Other trademarks in Class 005
- Other trademarks in Class 035
- Similar marks named CINPINETY
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 24, 2025 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Dec 24, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 24, 2025 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Dec 24, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 24, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 22, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 1, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 1, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 30, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 30, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jan 30, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 14, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 14, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 13, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Oct 25, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 25, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Oct 25, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 12, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 11, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 11, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 11, 2023 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Oct 3, 2023 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Oct 3, 2023 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 3, 2023 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 2, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 30, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 30, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 22, 2023 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jul 5, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 11, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 11, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 28, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 27, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 26, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 21, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 17, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 13, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |